AVACEN Medical® Welcomes Anthony Shimkin as New Chief Executive Officer
An industry veteran, Shimkin brings more than 25 years of medical and technology commercialization experience to AVACEN.
“As we continue to expand globally, Anthony’s knowledge and deep industry expertise will prove instrumental to our strategic growth,” said Thomas G. Muehlbauer, Chairman and co-founder of AVACEN Medical.
CARLSBAD, Calif., May 4, 2022 /PRNewswire/ — AVACEN Medical, an innovator, manufacturer, and marketer of safe, easy to use, noninvasive drug-free alternatives for pain management, today announced the appointment of Anthony Shimkin as CEO. With more than 25 years of medical and technology commercialization experience, Shimkin will be responsible for driving brand awareness, expanding AVACEN’s go-to-market strategy and increasing revenue growth.
“We are thrilled to welcome Anthony to the AVACEN Medical team,” said Thomas G. Muehlbauer, Chairman and co-founder of AVACEN Medical. “As we continue to expand globally, Anthony’s knowledge and deep industry expertise will prove instrumental to our strategic growth.
Also See San Diego Business Journal
See Page 9-12 in the San Diego Business Journal
